MedPath

A research study to compare pain relief between external oblique intercostal plane block and intravenous morphine in upper abdominal surgeries

Phase 3
Conditions
Health Condition 1: C168- Malignant neoplasm of overlappingsites of stomach
Registration Number
CTRI/2024/01/060995
Lead Sponsor
ivedhyaa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients who report moderate to severe upper abdominal pain, defined as a pain score on the numerical rating scale (NRS) of 0-10 as 4 or above for the first three days (POD 0,1,2 and 3) at rest or due to movement or spirometry, in the postoperative period will be included both elective and emergency surgeries

2.Patient who have given informed consent for the procedure.

3.Age of 18 and above

4, Surgeries with upper abdominal incisions including gastric surgeries, splenectomy, cholecystectomy, hepatectomy will be included for the study.

Exclusion Criteria

1.renal diseases with elevated serum creatinine level more than 1.5mg%

2.Local skin site infection at the site of epidural or at the site of the EOIPB as identified before surgery

3.Patient refusal to give consent for epidural or blocks

4.History of known allergies to local anaesthetics or morphine

.Suspected bowel obstruction : in this case we cannot use opioids

6.Patient would get discharged in less than 24 hours.

7.Drowsy patient who cannot tell about the pain score appropriately

8.Patients in whom epidural catheter will not be placed (as known preoperatively due to low platelet count or altered coagulation profile)

9.Patients who have been treated with tablet morphine in the preoperative period for pain

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean requirement of intravenous morphine in either groups as rescue analgesicTimepoint: Mean requirement of intravenous morphine in either groups as rescue analgesic upto 24 hours
Secondary Outcome Measures
NameTimeMethod
Pain Intensity Difference <br/ ><br>Side Effects <br/ ><br>Sum of the pain intensity differenceTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath